A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CLA / caseous lymphadenitis

[Related PubMed/MEDLINE]
Total Number of Papers: 80
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CLA  (>> Co-occurring Abbreviation)
Long Form:   caseous lymphadenitis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A panel of recombinant proteins for the serodiagnosis of caseous lymphadenitis in goats and sheep. ELISA
2019 Comparison of postmortem inspection procedures for detecting caseous lymphadenitis of Australian sheep and goats. ---
2019 Establishment of an objective endpoint in mice model for caseous lymphadenitis vaccine trials. ---
2018 Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis. IL, rPLD
2018 Caseous Lymphadenitis Caused by Corynebacterium pseudotuberculosis in Alpine Chamois (Rupicapra r. rupicapra): a Review of 98 Cases. ---
2018 Evaluation of specific and non-specific immune response of four vaccines for caseous lymphadenitis in sheep challenged. PLD
2018 Genome Sequence of Corynebacterium pseudotuberculosis Strain KM01, Isolated from the Abscess of a Goat in Kunming, China. ---
2018 Immune-Informatic Analysis and Design of Peptide Vaccine From Multi-epitopes Against Corynebacterium pseudotuberculosis. ---
2018 Responses of haptoglobin and serum amyloid A in goats inoculated intradermally with C. pseudotuberculosis and mycolic acid extract immunogen. Hp, SAA
10  2017 Endemic caseous lymphadenitis in a wild Caprinae population. ---
11  2017 Identification of new Corynebacterium pseudotuberculosis antigens by immunoscreening of gene expression library. bp, PCR
12  2017 Recombinant esterase from Corynebacterium pseudotuberculosis in DNA and subunit recombinant vaccines partially protects mice against challenge. ---
13  2016 Immunological characterization of diphtheria toxin recovered from Corynebacterium pseudotuberculosis. C. diphtheriae, C. pseudotuberculosis, C. ulcerans, CF, DT, OSD
14  2016 In silico identification of Corynebacterium pseudotuberculosis antigenic targets and application in immunodiagnosis. MED, ROC
15  2016 Influence of Corynebacterium pseudotuberculosis infection on level of acute phase proteins in goats. Hp, PLD, SAA
16  2016 Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression. ---
17  2016 Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain. rCP40
18  2016 Reproductive Pathological Changes Associated with Experimental Subchronic Corynebacterium pseudotuberculosis Infection in Nonpregnant Boer Does. ---
19  2016 Vaccination against Corynebacterium pseudotuberculosis infections controlling caseous lymphadenitis (CLA) and oedematousskin disease. C. pseudotuberculosis, OSD, rPLD
20  2016 Welfare effects of a disease eradication programme for dairy goats. CAE, HG
21  2015 An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets. Cp, HD, PAIs
22  2015 Assessment of blood changes post-challenge with Corynebacterium pseudotuberculosis and its exotoxin (phospholipase D): A comprehensive study in goat. Hb, PLD
23  2015 Caprine arthritis encephalitis and caseous lymphadenitis in goats: use of bulk tank milk ELISAs for herd-level surveillance. BTM, CAE
24  2015 Lack of interference with diagnostic testing for tuberculosis in goats experimentally exposed to Corynebacterium pseudotuberculosis. IFN, TB
25  2015 Serology and clinical relevance of Corynebacterium pseudotuberculosis in native Korean goats (Capra hircus coreanae). ---
26  2014 An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge. ---
27  2014 C. pseudotuberculosis Phop confers virulence and may be targeted by natural compounds. PhoR, TCS
28  2014 Caseous lymphadenitis in small ruminants in Egypt. Clinical, epidemiological and prophylactic aspects. ---
29  2014 Characterization of the Opp peptide transporter of Corynebacterium pseudotuberculosis and its role in virulence and pathogenicity. Opp
30  2014 Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis. ---
31  2014 Management of a caseous lymphadenitis outbreak in a new Iberian ibex (Capra pyrenaica) stock reservoir. APP, ASG, Hp, PCV
32  2014 Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis. Cp, SBDD
33  2014 Serological proteome analysis of Corynebacterium pseudotuberculosis isolated from different hosts reveals novel candidates for prophylactics to control caseous lymphadenitis. SERPA
34  2014 The Norwegian Healthier Goats programme--a financial cost-benefit analysis. CAE, CBA, NPV
35  2013 Association between haptoglobin and IgM levels and the clinical progression of caseous lymphadenitis in sheep. BLR, Cp, Hp, p.i
36  2013 Conserved host-pathogen PPIs. Globally conserved inter-species bacterial PPIs based conserved host-pathogen interactome derived novel target in C. pseudotuberculosis, C. diphtheriae, M. tuberculosis, C. ulcerans, Y. pestis, and E. coli targeted by Piper betel compounds. ACK, Cp, PPI
37  2013 Differences in the antigen structures of Corynebacterium pseudotuberculosis and the induced humoral immune response in sheep and goats. Cp, PLD
38  2013 Rapid detection of Corynebacterium pseudotuberculosis in clinical samples from sheep. NADP, PCR, PIP
39  2012 Frequency of caseous lymphadenitis (CLA) in sheep slaughtered in an abattoir in Tabriz: comparison of bacterial culture and pathological study. ---
40  2012 Inspection of lymph nodes for caseous lymphadenitis and its effect on the density of microbes on sheep carcasses. ---
41  2012 Molecular characterization of Corynebacterium pseudotuberculosis isolated from goats using ERIC-PCR. ERIC, PE
42  2012 The Corynebacterium pseudotuberculosis in silico predicted pan-exoproteome. PSE, SEC
43  2011 A combined approach for comparative exoproteome analysis of Corynebacterium pseudotuberculosis. TPP
44  2011 Control of caseous lymphadenitis. ---
45  2011 Corynebacterium pseudotuberculosis secreted antigen-induced specific gamma-interferon production by peripheral blood leukocytes: potential diagnostic marker for caseous lymphadenitis in sheep and goats. ---
46  2011 Haptoglobin and fibrinogen concentrations and leukocyte counts in the clinical investigation of caseous lymphadenitis in sheep. ---
47  2011 High sero-prevalence of caseous lymphadenitis identified in slaughterhouse samples as a consequence of deficiencies in sheep farm management in the state of Minas Gerais, Brazil. ---
48  2011 Molecular characterization of the Corynebacterium pseudotuberculosis hsp60-hsp10 operon, and evaluation of the immune response and protective efficacy induced by hsp60 DNA vaccination in mice. HSPs
49  2010 Control of caseous lymphadenitis in six sheep flocks using clinical examination and regular ELISA testing. PLD
50  2010 Epidemiological features of Morel's disease in goats. CAEV
51  2010 High seroprevalence of caseous lymphadenitis in Brazilian goat herds revealed by Corynebacterium pseudotuberculosis secreted proteins-based ELISA. ELISA
52  2010 Survey of genome organization and gene content of Corynebacterium pseudotuberculosis. GSSs
53  2010 The control of Corynebacterium pseudotuberculosis infection in sheep flocks: a mathematical model of the impact of vaccination, serological testing, clinical examination and lancing of abscesses. ---
54  2009 Development of a surface plasmon resonance-based assay for the detection of Corynebacterium pseudotuberculosis infection in sheep. PLD
55  2008 A survey of caseous lymphadenitis in small ruminant farms from two districts in Perak, Malaysia -- Kinta and Hilir Perak. AGPT, ELISA
56  2008 Parameter estimation and simulations of a mathematical model of Corynebacterium pseudotuberculosis transmission in sheep. ---
57  2008 Performance of a whole blood interferon-gamma assay for detection and eradication of caseous lymphadenitis in sheep. EIA, IFN-gamma
58  2007 Acute phase protein response in an experimental model of ovine caseous lymphadenitis. AGP, APP, Hp, SAA
59  2007 Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis. ---
60  2007 Development and validation of an ELISA to detect antibodies to Corynebacterium pseudotuberculosis in ovine sera. ELISAs, ROC
61  2007 Molecular genotyping of multinational ovine and caprine Corynebacterium pseudotuberculosis isolates using pulsed-field gel electrophoresis. PFGE
62  2007 Multiplex PCR assay for identification of Corynebacterium pseudotuberculosis from pure cultures and for rapid detection of this pathogen in clinical samples. mPCR
63  2007 [Diagnosis of caseous lymphadenitis in sheep from Patagonia]. ---
64  2006 A serological investigation of caseous lymphadenitis in four flocks of sheep. ---
65  2006 Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. ---
66  2003 Experimental Corynebacterium pseudotuberculosis primary infection in goats: kinetics of IgG and interferon-gamma production, IgG avidity and antigen recognition by Western blotting. IFN-gamma
67  2003 Prevalence of caseous lymphadenitis and usage of caseous lymphadenitis vaccines in sheep flocks. ---
68  2000 Effect of shearing on the incidence of caseous lymphadenitis in Awassi sheep in Jordan. ---
69  1999 Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D. PLD
70  1998 The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines. ---
71  1998 Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep. ---
72  1997 Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis. ---
73  1995 Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D gene. PLD
74  1995 The spread of Corynebacterium pseudotuberculosis infection to unvaccinated and vaccinated sheep. ---
75  1993 Acquired immunity after primary caseous lymphadenitis in sheep. ---
76  1991 A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis in sheep and goat flocks. ---
77  1991 Lymphocyte subpopulations in pyogranulomas of caseous lymphadenitis. ---
78  1991 The effect of antibody to caseous lymphadenitis in ewes on the efficacy of vaccination in lambs. ---
79  1987 The role of Corynebacterium pseudotuberculosis lung lesions in the transmission of this bacterium to other sheep. ---
80  1984 Ovine caseous lymphadenitis: disease prevalence, lesion distribution, and thoracic manifestations in a population of mature culled sheep from western United States. ---